Pierre Vandepapeliere

Chief Executive Officer at

Amyl Therapeutics SRL

Health Technology

Consumer Services

Profile

Pierre Vandepapeliere is the founder of Amyl Therapeutics SRL, serving as Chief Executive & Medical Officer since 2020.
Former positions include Director-Clinical Research at GlaxoSmithKline Biologicals SA, Chief Medical Officer at Neovacs SA, Principal at AstraZeneca, Inc. in 1990, Chief Medical Officer at ImCyse SA in 2019, and Chief Medical Officer & VP-Clinical Development at Abivax SA. Education includes a doctorate from Ghent University and both undergraduate and doctorate degrees from Facultés Universitaires Notre-Dame de la Paix.

Pierre Vandepapeliere active positions

Companies	Position	Start
Amyl Therapeutics SRL Amyl Therapeutics SRL BiotechnologyHealth Technology Operates as a preclinical biotechnology company	Chief Executive Officer	31/12/2019

All active positions of Pierre Vandepapeliere

Former positions of Pierre Vandepapeliere

Companies	Position	End
ImCyse SA ImCyse SA BiotechnologyHealth Technology Engages in the development of curative therapies in the field of immune and allergic pathologies	Chief Executive Officer	06/08/2019
AstraZeneca, Inc. AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines	Corporate Officer/Principal	30/12/1990
ABIVAX	Chief Tech/Sci/R&D Officer	-
GlaxoSmithKline Biologicals SA GlaxoSmithKline Biologicals SA BiotechnologyHealth Technology Operates biopharma and pharmaceutical company	Chief Tech/Sci/R&D Officer	-
NEOVACS	Chief Tech/Sci/R&D Officer	-

See the detail of Pierre Vandepapeliere's experience

Training of Pierre Vandepapeliere

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Pierre Vandepapeliere's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	8
GlaxoSmithKline Biologicals SA GlaxoSmithKline Biologicals SA BiotechnologyHealth Technology Operates biopharma and pharmaceutical company	Health Technology
Neovacs SA Neovacs SA Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapies	Health Technology
Ghent University Ghent University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Facultés Universitaires Notre-Dame de la Paix Facultés Universitaires Notre-Dame de la Paix Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
AstraZeneca, Inc. AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines	Health Technology
ImCyse SA ImCyse SA BiotechnologyHealth Technology Engages in the development of curative therapies in the field of immune and allergic pathologies	Health Technology
Abivax SA Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms	Health Technology
Amyl Therapeutics SRL Amyl Therapeutics SRL BiotechnologyHealth Technology Operates as a preclinical biotechnology company	Health Technology